Back to Oncology
OncologyEvidence-Based

PET Total Lesion Glycolysis (TLG)

Total lesion glycolysis: metabolic tumor volume multiplied by mean SUV. Prognostic PET metric in oncology.

Clinical Input Parameters

mL
Range: 0.1 — 10000 mL
Range: 0.1 — 100
Clinical Assessment
Awaiting Parameters
tlg
—g
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The PET Total Lesion Glycolysis (TLG) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within oncology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

TLG = Metabolic Tumor Volume (mL) x SUVmean

Clinical Pearls & Practice Notes

  • Higher TLG associated with worse prognosis across multiple cancers
  • Requires consistent segmentation method for MTV

Evidence & Literature Citations

  1. Larson SM, Erdi Y, Akhurst T, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. Clin Positron Imaging. 1999;2(3):159-171.

Score Interpretation Ranges

Low TLG0 – 100 pts

Relatively low total lesion glycolysis

Moderate TLG100 – 500 pts

Moderate total lesion glycolysis

High TLG500 – pts

High total lesion glycolysis

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.